# Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept

> **NCT03396861** · PHASE1 · TERMINATED · sponsor: **Tufts Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Irvine-Gass Syndrome

## Interventions

- **DRUG:** Aflibercept

## Key facts

- **NCT ID:** NCT03396861
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-22
- **Primary completion:** 2019-08-18
- **Final completion:** 2020-01-02
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03396861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03396861, "Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03396861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*